These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 19765463

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. [Post-transplant lymphoproliferative disease in liver transplant recipients--Merkur University Hospital single center experience].
    Filipec-Kanizaj T, Budimir J, Colić-Cvrlje V, Kardum-Skelin I, Sustercić D, Naumovski-Mihalić S, Mrzljak A, Kolonić SO, Sobocan N, Bradić T, Dolić ZM, Kocman B, Katicić M, Zidovec-Lepej S, Vince A.
    Acta Med Croatica; 2011 Sep; 65 Suppl 1():37-43. PubMed ID: 23126028
    [Abstract] [Full Text] [Related]

  • 43. Liver transplantation in the United States: a report from the UNOS Liver Transplant Registry.
    Smith CM, Davies DB, McBride MA.
    Clin Transpl; 1999 Sep; ():23-34. PubMed ID: 11038623
    [Abstract] [Full Text] [Related]

  • 44. Posttransplantation lymphoproliferative disorder in liver recipients: characteristics, management, and outcome.
    Ben-Ari Z, Amlot P, Lachmanan SR, Tur-Kaspa R, Rolles K, Burroughs AK.
    Liver Transpl Surg; 1999 May; 5(3):184-91. PubMed ID: 10226108
    [Abstract] [Full Text] [Related]

  • 45. Lymphoproliferative disorders after adult kidney transplant: epidemiology and comparison of registry report with claims-based diagnoses.
    Kasiske BL, Kukla A, Thomas D, Wood Ives J, Snyder JJ, Qiu Y, Peng Y, Dharnidharka VR, Israni AK.
    Am J Kidney Dis; 2011 Dec; 58(6):971-80. PubMed ID: 21930332
    [Abstract] [Full Text] [Related]

  • 46. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
    Muti G, Cantoni S, Oreste P, Klersy C, Gini G, Rossi V, D'Avanzo G, Comoli P, Baldanti F, Montillo M, Nosari A, Morra E, Cooperative Study Group on PTLDs.
    Haematologica; 2002 Jan; 87(1):67-77. PubMed ID: 11801467
    [Abstract] [Full Text] [Related]

  • 47. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression.
    Armitage JM, Kormos RL, Stuart RS, Fricker FJ, Griffith BP, Nalesnik M, Hardesty RL, Dummer JS.
    J Heart Lung Transplant; 1991 Jan; 10(6):877-86; discussion 886-7. PubMed ID: 1661607
    [Abstract] [Full Text] [Related]

  • 48. Posttransplant lymphoproliferative disorders following liver transplantation: Where are we now?
    Dierickx D, Cardinaels N.
    World J Gastroenterol; 2015 Oct 21; 21(39):11034-43. PubMed ID: 26494960
    [Abstract] [Full Text] [Related]

  • 49. Posttransplantation lymphoproliferative disorder in pediatric liver transplantation.
    Heo JS, Park JW, Lee KW, Lee SK, Joh JW, Kim SJ, Lee HH, Lee DS, Choi SH, Seo JM, Choe YH.
    Transplant Proc; 2004 Oct 21; 36(8):2307-8. PubMed ID: 15561231
    [Abstract] [Full Text] [Related]

  • 50. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.
    Tai CC, Curtis JL, Szmuszkovicz JR, Horn MV, Ford HR, Woo MS, Wang KS.
    J Pediatr Surg; 2008 Dec 21; 43(12):2174-7. PubMed ID: 19040929
    [Abstract] [Full Text] [Related]

  • 51. Increased risk for posttransplant lymphoproliferative disease in recipients of liver transplants with hepatitis C.
    McLaughlin K, Wajstaub S, Marotta P, Adams P, Grant DR, Wall WJ, Jevnikar AM, Rizkalla KS.
    Liver Transpl; 2000 Sep 21; 6(5):570-4. PubMed ID: 10980055
    [Abstract] [Full Text] [Related]

  • 52. No Increased Risk of Posttransplant Lymphoproliferative Disorder Following Alemtuzumab Induction in Kidney Transplant.
    Oliver M, Mitro G, Tenbrink P, Alharthi S, Bedford N, Wu J, Gohara A, Jordan M, Zaremba C, Rees M, Ortiz J.
    Exp Clin Transplant; 2019 Jun 21; 17(3):320-325. PubMed ID: 29363415
    [Abstract] [Full Text] [Related]

  • 53. Treatment of posttransplant lymphoproliferative disorder with the anti-CD20 monoclonal antibody rituximab alone in an adult after liver transplantation: a new drug in therapy of patients with posttransplant lymphoproliferative disorder after solid organ transplantation?
    Oertel SH, Anagnostopoulos I, Bechstein WO, Liehr H, Riess HB.
    Transplantation; 2000 Feb 15; 69(3):430-2. PubMed ID: 10706055
    [Abstract] [Full Text] [Related]

  • 54. Epstein-Barr Virus-negative Marginal Zone Lymphoma as an Uncommon Form of Monomorphic Posttransplant Lymphoproliferative Disorder.
    Galera P, Flavin R, Savage NM, Saksena A, Gong S, Wang HY, Swan N, Xi L, Raffeld M, Pittaluga S, Jaffe ES.
    Am J Surg Pathol; 2020 Oct 15; 44(10):1340-1352. PubMed ID: 32554995
    [Abstract] [Full Text] [Related]

  • 55. Primary Cutaneous Anaplastic Large-Cell Lymphoma With 6p25.3 Rearrangement in a Cardiac Transplant Recipient: A Case Report and Review of the Literature.
    Olson LC, Cheng E, Mathew S, Torres-Quinones M, Magro C.
    Am J Dermatopathol; 2016 Jun 15; 38(6):461-5. PubMed ID: 26863058
    [Abstract] [Full Text] [Related]

  • 56. Peripheral T-Cell Lymphoma: A Posttransplant Lymphoproliferative Disorder Presenting as a Jejunal Mass in a Renal Transplant Recipient.
    Kakkar A, Pradeep I, Singh G, Dinda A, Agarwal SK.
    Exp Clin Transplant; 2018 Oct 15; 16(5):617-619. PubMed ID: 27915968
    [Abstract] [Full Text] [Related]

  • 57. Small Intestine Posttransplant Lymphoproliferative Disorder in a Kidney Transplant Recipient: A Case Report.
    Radunovic D, Dapcevic M, Prelevic V, Tomovic F, Ratkovic M, Basic-Jukic N.
    Exp Clin Transplant; 2021 Jan 15; 19(1):77-79. PubMed ID: 33441059
    [Abstract] [Full Text] [Related]

  • 58. Incidence, management, and outcome of posttransplant lymphoproliferative disease in pediatric liver transplant recipients.
    Molmenti EP, Nagata D, Roden J, Squires R, Molmenti H, Casey D, Fasola C, Lopez MJ, Winick N, McPhail W, D'Amico L, Goldstein R, Levy M, Fasola C, Andersen J, Klintmalm G.
    Transplant Proc; 2001 Jan 15; 33(1-2):1727. PubMed ID: 11267487
    [No Abstract] [Full Text] [Related]

  • 59. A Mimic of Posttransplant Lymphoproliferative Disease Following Liver Transplant.
    Kitchens WH, Jaye DL, Wedd JP, Magliocca JF.
    Exp Clin Transplant; 2020 Nov 15; 18(6):741-743. PubMed ID: 29108510
    [Abstract] [Full Text] [Related]

  • 60. Lymphomas occurring late after solid-organ transplantation: influence of treatment on the clinical outcome.
    Dotti G, Fiocchi R, Motta T, Mammana C, Gotti E, Riva S, Cornelli P, Gridelli B, Viero P, Oldani E, Ferrazzi P, Remuzzi G, Barbui T, Rambaldi A.
    Transplantation; 2002 Oct 27; 74(8):1095-102. PubMed ID: 12438953
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.